Searchable abstracts of presentations at key conferences in endocrinology

ea0037gp.15.06 | Diabetes and obesity – basic | ECE2015

Activation of GPR120 by lipid agonists modulates glucagon secretion in pancreatic islets and improves glucose tolerance in mice

Gormley Noella , Flatt Peter , McKillop Aine

GPR120 is a rhodopsin-like GPCR that has a high affinity for long-chain saturated fatty acids 14–18 carbons and unsaturated fatty acids 16–22 carbons. The beneficial effects of GPR120 on β-cell function and glucose homeostasis have recently been reported however its role in glucagon secretion is unknown. GPR120 and glucagon expression were examined by double immunohistochemical studies using a glucagon secreting cell line (α-TC1.9) and pancreatic tissue fro...

ea0004dp32 | Diabetes, metabolism and cardiovascular | SFE2002

Nateglinide effects on the secretion of glycated insulin and glucose tolerance in subjects with Type 2 diabetes

Lindsay J , McKillop A , Mooney M , O'Harte F , Flatt P , Bell P

Aims: Glycated insulin exhibits impaired glucose-lowering ability and increasing evidence supports a role for glycation of insulin in the insulin resistant state of Type 2 diabetes. We used a novel radioimmunoassay to evaluate the effect of the insulin secretagogue nateglinide on plasma glycated insulin in Type 2 diabetes. Methods: Ten patients (5M/5F, age 57.8±1.9 years, HbA1c 7.6±0.5%, fasting plasma glucose 9.4±1.2millimols per litre, creatinine 81.6&pl...

ea0003p85 | Diabetes & Metabolism | BES2002

Demonstration of diurnal variation of plasma glycated insulin in type 2 diabetes

Lindsay J , McKillop A , Mooney M , O'Harte F , Bell P , Flatt P

Aims: Increasing evidence supports the role of glycated insulin in the insulin resistant state of type 2 diabetes. We measured 24-hour profiles of plasma glycated insulin, using a novel radioimmunoassay, to evaluate the effects of meal stimulated insulin secretion and the fasting state on production of plasma glycated insulin in type 2 diabetes. Methods: Patients (n=6, HbA1c 7.2±0.6%, fasting plasma glucose 7.4±0.7 mmol l-1, BMI 35.7±3.5 kg m<su...